The effect of vitamin D on different human cells, with emphasis on burns and ICU

Created April 2018

Vitamin D status and its influence on outcomes following major burn injury and critical illness

Burns & Trauma 20186:11, https://doi.org/10.1186/s41038-018-0113-4, 16 April 2018

Khaled Al-Tarrah, Martin Hewison, Naiem Moiemen† and Janet M. Lord† † = Contributed equally

* Wounds and burns healed with Vitamin D * Bone fractures after a burn - none if vitamin D, 6 if no vitamin D – RCT May 2015 * * Trauma and surgery category listing has items along with related searches * Injection category listing has items along with related searches * Sepsis is both prevented and treated by Vitamin D - many studies * Vitamin D levels might be raised very quickly Currently: Days, Future: Hours?** * Can burn pain be relieved by 4 g of Omega-3 and 2,000 IU of vitamin D – RCT due 2021 1. Studies in both Trauma-Surgery and Skin categories {category}

📄 Download the PDF from VitaminDWiki

Vitamin D deficiency is common among the general population. It is also observed in up to 76% of critically ill patients. Despite the high prevalence of hypovitaminosis D in critical illness, vitamin D is often overlooked by medical staff as the clinical implications and consequences of vitamin D deficiency in acute contexts remain to be fully understood. Vitamin D has a broad range of pleotropic effects on various processes and systems including the immune-inflammatory response. 1α,25-dihydroxyvitamin D (1,25(OH)2D), has been shown to promote a tolerogenic immune response limiting deleterious inflammatory effects, modulation of the innate immune system, and enhancement of anti-microbial peptides. Vitamin D deficiency is frequently observed in critically ill patients and has been related to extrinsic causes (i.e., limited sunlight exposure), magnitude of injury/illness, or the treatment started by medical doctors including fluid resuscitation. Low levels of vitamin D in critically ill patients have been associated with sepsis, organ failure, and mortality. Despite this, there are subpopulations of critical illness, such as burn patients, where the literature regarding vitamin D status and its influence on outcomes remain insufficient. Thermal injury results in damage to both burned and non-burned tissues, as well as induces an exaggerated and persistent immune-inflammatory and hypermetabolic response. In this review, we propose potential mechanisms in which burn injury affects the vitamin D status and summarizes current literature investigating the influence of vitamin D status on outcomes. In addition, we reviewed the literature and trials investigating vitamin D supplementation in critically ill patients and discuss the therapeutic potential of vitamin D supplementation in burn and critically ill patients. We also highlight current limitations of studies that have investigated vitamin D status and supplementation in critical illness. Thermal injury influences vitamin D status. More studies investigating vitamin D depletion in burn patients and its influence on prognosis, via standardized methodology, are required to reach definitive conclusions and influence clinical practice.

Table 1 Effects of vitamin D on various human cell types and tissues

Adipocytes ^{^[105]}

Inhibits intracellular fat accumulation

Enhances basallipolysis without cell toxicity

Upregulation of p-oxidation-related genes, lipolytic enzymes, and vitamin D-responsive genes

Increased levels of nicotinamide adenine dinucleotide and sirtulin 1 expression

Cardiomyocytes ^{^{[106, 107]}}

Inhibition of cellproliferation without apoptosis

Downregulation of expression of genes associated with cell cycle regulation

Promotes cardiomyotube formation

Induces cardiac differentiation

Hepatocytes [108-110]

Protects against insulin resistance

Downregulates fibrogenic TGF-p signaling

Anti-inflammatory effects by inhibiting monocyte activation and TNF-a and IL-1 expression

Myocytes ^{^[111,112]}

Modulation of calcium homeostasis and influx

Induces cellular proliferation and differentiation

Protects against insulin resistance

Stimulation of arachidonic acid mobilization

Nephrocytes ^{^[113]}

Upregulation of cellular metabolic activity, IL-6, and reactive oxygen species

Restoration of transepithelial barrier function

Neurons ^{^{[114, 115]}}

Neuroactive steroid modulating spontaneous regular firing, actin potential duration, and intrinsic excitability

Enhances sensitivity to neurotransmitters and neurotransmitter receptors

Upregulation of neuronal growth factors, neurotrophin 3, and glial cell line-derived neurotrophic factor

T cells ^{^{[17, 116]}}

Inhibits Th1/Th17 chemokine/ cytokine secretion (CXCL-10, IFN-γ, TNF-α, and IL-17)

Enhances Th2 cytokine release (IL-4 and IL-5)

B cells ^{^[117]}

Downregulates the proliferation of memory B cells

Inhibits plasma cell differentiation

Reduces Ig production

Antigenpresenting cells ^{^[122]}

Inhibits the expression of class II MHC molecules (HLA-DR)

Inhibition of co-stimulating molecule expression (CD80, CD83, and CD86)

Augments chemotaxis and phagocytosis of monocytes

Downregulates the maturation of dendritic cells

Induces tolerogenic dendritic cells capable of inducing Treg cells

Inhibits IL-12 p70 release

Decreases macrophagestimulated pro-inflammatory cytokine production (IL-1, IL-1β, IL-6, IL-8, MCP-1, and RANTES)

NK cells ^{^[122]}

Inhibition of NK cell development and differentiation

Reduced INF-γ and cytotoxicity

Tags: Immunity Skin Trauma and surgery